Price movement over the last 24 hours
Ashmore Asset Management Indonesia Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Ashmore Asset Management Indonesia Tbk trades at Rp322 (market cap 715.56B, 25.9K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 160.57B, 2.51M 24h volume). The key difference: Ashmore Asset Management Indonesia Tbk is far larger — about 4.5× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (2.51M versus 25.9K). Which is the better fit depends on your goals.
| AMOR | OBAT | |
|---|---|---|
Market Cap | 715.56B | 160.57B |
Volume | 25.9K | 2.51M |
Lot | 259 | 25.09K |
Turnover | 8.31M | 636.74M |
Average Price | 320.73 | 253.78 |
Value | 8.31M | 636.74M |
Indicative Equilibrium Price | 322 | 242 |
Indicative Equilibrium Volume | 1 | 146 |
Trailing returns across standard periods
Latest headlines on both assets
PT Ashmore Asset Management Indonesia Tbk (the Company) initially established under the name of PT Buana Megah Abadi, is an Indonesian domiciled Company. The Company was established based on notary deed No. 250 dated 29 January 2010 of Doctor Irawan Soerodjo, SH.MSi.
Read more on AMOR →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →